Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues

ABSTRACT Despite recent advances in diagnostic and therapeutic methods in antifungal research, aspergillosis still remains a leading cause of morbidity and mortality. One strategy to address this problem is to enhance the activity spectrum of known antifungals, and we now report the first successful...

Full description

Bibliographic Details
Published in:Antimicrobial Agents and Chemotherapy
Main Authors: Malhotra, Shashwat, Singh, Seema, Rana, Neha, Tomar, Shilpi, Bhatnagar, Priyanka, Gupta, Mohit, Singh, Suraj K., Singh, Brajendra K., Chhillar, Anil K., Prasad, Ashok K., Len, Christophe, Kumar, Pradeep, Gupta, Kailash C., Varma, Anjani J., Kuhad, Ramesh C., Sharma, Gainda L., Parmar, Virinder S., Richards, Nigel G. J.
Format: Article in Journal/Newspaper
Language:English
Published: American Society for Microbiology 2017
Subjects:
Online Access:http://dx.doi.org/10.1128/aac.00273-17
https://journals.asm.org/doi/pdf/10.1128/AAC.00273-17
id crasmicro:10.1128/aac.00273-17
record_format openpolar
spelling crasmicro:10.1128/aac.00273-17 2024-09-15T17:44:44+00:00 Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues Malhotra, Shashwat Singh, Seema Rana, Neha Tomar, Shilpi Bhatnagar, Priyanka Gupta, Mohit Singh, Suraj K. Singh, Brajendra K. Chhillar, Anil K. Prasad, Ashok K. Len, Christophe Kumar, Pradeep Gupta, Kailash C. Varma, Anjani J. Kuhad, Ramesh C. Sharma, Gainda L. Parmar, Virinder S. Richards, Nigel G. J. 2017 http://dx.doi.org/10.1128/aac.00273-17 https://journals.asm.org/doi/pdf/10.1128/AAC.00273-17 en eng American Society for Microbiology https://journals.asm.org/non-commercial-tdm-license Antimicrobial Agents and Chemotherapy volume 61, issue 8 ISSN 0066-4804 1098-6596 journal-article 2017 crasmicro https://doi.org/10.1128/aac.00273-17 2024-07-22T04:08:52Z ABSTRACT Despite recent advances in diagnostic and therapeutic methods in antifungal research, aspergillosis still remains a leading cause of morbidity and mortality. One strategy to address this problem is to enhance the activity spectrum of known antifungals, and we now report the first successful application of Candida antarctica lipase (CAL) for the preparation of optically enriched fluconazole analogues. Anti- Aspergillus activity was observed for an optically enriched derivative, (−)- S -2-(2′,4′-difluorophenyl)-1-hexyl-amino-3-(1‴,2‴,4‴)triazol-1‴-yl-propan-2-ol, which exhibits MIC values of 15.6 μg/ml and 7.8 μg/disc in broth microdilution and disc diffusion assays, respectively. This compound is tolerated by mammalian erythrocytes and cell lines (A549 and U87) at concentrations of up to 1,000 μg/ml. When incorporated into dextran nanoparticles, the novel, optically enriched fluconazole analogue exhibited improved antifungal activity against Aspergillus fumigatus (MIC, 1.63 μg/ml). These results not only demonstrate the ability of biocatalytic approaches to yield novel, optically enriched fluconazole derivatives but also suggest that enantiomerically pure fluconazole derivatives, and their nanotized counterparts, exhibiting anti- Aspergillus activity may have reduced toxicity. Article in Journal/Newspaper Antarc* Antarctica ASM Journals (American Society for Microbiology) Antimicrobial Agents and Chemotherapy 61 8
institution Open Polar
collection ASM Journals (American Society for Microbiology)
op_collection_id crasmicro
language English
description ABSTRACT Despite recent advances in diagnostic and therapeutic methods in antifungal research, aspergillosis still remains a leading cause of morbidity and mortality. One strategy to address this problem is to enhance the activity spectrum of known antifungals, and we now report the first successful application of Candida antarctica lipase (CAL) for the preparation of optically enriched fluconazole analogues. Anti- Aspergillus activity was observed for an optically enriched derivative, (−)- S -2-(2′,4′-difluorophenyl)-1-hexyl-amino-3-(1‴,2‴,4‴)triazol-1‴-yl-propan-2-ol, which exhibits MIC values of 15.6 μg/ml and 7.8 μg/disc in broth microdilution and disc diffusion assays, respectively. This compound is tolerated by mammalian erythrocytes and cell lines (A549 and U87) at concentrations of up to 1,000 μg/ml. When incorporated into dextran nanoparticles, the novel, optically enriched fluconazole analogue exhibited improved antifungal activity against Aspergillus fumigatus (MIC, 1.63 μg/ml). These results not only demonstrate the ability of biocatalytic approaches to yield novel, optically enriched fluconazole derivatives but also suggest that enantiomerically pure fluconazole derivatives, and their nanotized counterparts, exhibiting anti- Aspergillus activity may have reduced toxicity.
format Article in Journal/Newspaper
author Malhotra, Shashwat
Singh, Seema
Rana, Neha
Tomar, Shilpi
Bhatnagar, Priyanka
Gupta, Mohit
Singh, Suraj K.
Singh, Brajendra K.
Chhillar, Anil K.
Prasad, Ashok K.
Len, Christophe
Kumar, Pradeep
Gupta, Kailash C.
Varma, Anjani J.
Kuhad, Ramesh C.
Sharma, Gainda L.
Parmar, Virinder S.
Richards, Nigel G. J.
spellingShingle Malhotra, Shashwat
Singh, Seema
Rana, Neha
Tomar, Shilpi
Bhatnagar, Priyanka
Gupta, Mohit
Singh, Suraj K.
Singh, Brajendra K.
Chhillar, Anil K.
Prasad, Ashok K.
Len, Christophe
Kumar, Pradeep
Gupta, Kailash C.
Varma, Anjani J.
Kuhad, Ramesh C.
Sharma, Gainda L.
Parmar, Virinder S.
Richards, Nigel G. J.
Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
author_facet Malhotra, Shashwat
Singh, Seema
Rana, Neha
Tomar, Shilpi
Bhatnagar, Priyanka
Gupta, Mohit
Singh, Suraj K.
Singh, Brajendra K.
Chhillar, Anil K.
Prasad, Ashok K.
Len, Christophe
Kumar, Pradeep
Gupta, Kailash C.
Varma, Anjani J.
Kuhad, Ramesh C.
Sharma, Gainda L.
Parmar, Virinder S.
Richards, Nigel G. J.
author_sort Malhotra, Shashwat
title Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
title_short Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
title_full Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
title_fullStr Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
title_full_unstemmed Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues
title_sort chemoenzymatic synthesis, nanotization, and anti-aspergillus activity of optically enriched fluconazole analogues
publisher American Society for Microbiology
publishDate 2017
url http://dx.doi.org/10.1128/aac.00273-17
https://journals.asm.org/doi/pdf/10.1128/AAC.00273-17
genre Antarc*
Antarctica
genre_facet Antarc*
Antarctica
op_source Antimicrobial Agents and Chemotherapy
volume 61, issue 8
ISSN 0066-4804 1098-6596
op_rights https://journals.asm.org/non-commercial-tdm-license
op_doi https://doi.org/10.1128/aac.00273-17
container_title Antimicrobial Agents and Chemotherapy
container_volume 61
container_issue 8
_version_ 1810492383853281280